key: cord-0321031-08v49ta0 authors: Pando-Naude, Victor; Toxto, Sebastian; Fernandez-Lozano, Sofia; Parsons, E. Christine; Alcauter, Sarael; Garza-Villarreal, Eduardo A. title: Gray and white matter morphology in substance use disorders: A neuroimaging systematic review and meta-analysis date: 2020-05-31 journal: bioRxiv DOI: 10.1101/2020.05.29.122812 sha: ac133eaf5efb7d1ab35bb803d747b3ad146f89da doc_id: 321031 cord_uid: 08v49ta0 Substance use disorders (SUDs) are characterized by a compulsion to seek and consume one or more substances of abuse, with a perceived loss of control and negative emotional state. Repeated use of a substance results in synaptic and morphological changes, secondary to toxicity and SUD pathology in the dopamine striato-thalamo-cortical and limbic pathways. These neuroadaptations seem to vary between studies, which could be related to divergent effects of substances, consumption severity or other unknown factors. We therefore identified studies investigating the effects of SUDs using volumetric whole-brain voxel-based morphometry (VBM) in gray (GM) and white matter (WM). We performed a systematic review and meta-analysis of VBM studies using the anatomic likelihood estimation (ALE) method implemented in GingerALE (PROSPERO pre-registration CRD42017071222). Fifty studies met inclusion criteria and were included in the final quantitative meta-analysis, with a total of 538 foci, 88 experiments and 4370 participants. We found convergence and divergence in brain regions and volume effects (higher vs lower volume) in GM and WM depending on the severity of consumption pattern and type of substance. Convergent pathology was evident across substances in GM of the insula, anterior cingulate cortex, putamen, and thalamus, and in WM of the thalamic radiation and internal capsule bundle. Divergent pathology between occasional use (cortical pathology) and addiction (cortical-subcortical pathology) provides evidence of a possible top-down neuroadaptation. Our findings indicate distinctive brain morphometry alterations in SUDs, which may inform our understanding of disease progression and ultimately therapeutic approaches. Substance use disorders (SUDs) refer to a wide range of alterations produced by the consumption of abuse substances or drugs. According to the Diagnostic and Statistical Manual of Mental Disorders (DSM-V) 1 , these substances include: alcohol, caffeine, cannabis, hallucinogens, inhalants, opioids, sedatives, hypnotics and anxiolytics, stimulants, tobacco and other. About 275 million people worldwide (around 5.6% of the global population aged 15-64 years) used substances at least once during 2016 2 and SUDs are recognized as a major public health issue. SUDs affect the reward system, involved in the reinforcement of behaviors and memory, and can lead to chronic use and dependency 3 . Initial substance reward is triggered by dopamine neurons in the ventral tegmental area (VTA), which project to the prefrontal cortex, amygdala and nucleus accumbens (NAc) 4, 5 , as well as other ascending monoamine fibers such as norepinephrine and other non-dopaminergic systems within frontal regions 6 . Additionally, dopaminergic neurons in the substantia nigra pars compacta (SNc) project to the dorsal striatum (nigrostriatal pathway), a pathway implicated in the emergence of habits 7 . A reinforcement effect seems to depend on dopaminergic signaling in the NAc, and chronic use may result in neuroadaptations of the dopamine striato-thalamo-cortical (prefrontal cortex, orbitofrontal cortex and the anterior cingulate cortex) and limbic pathways (amygdala and hippocampus) 4, 5 , especially in individuals who may be vulnerable due to genetic and/or environmental factors 8 . Other endogenous systems, such as the opioid and cannabinoid systems, may also contribute to the reinforcement effect by modulating hedonic responses or inhibiting negative affective states 9 . Ultimately, repeated dopaminergic stimulation from substance use may alter multiple neurotransmitter systems, which in consequence may disrupt neuronal excitability and affect neuroplastic mechanisms (i.e. glutamatergic system) 9,10 . Such substance-induced neuroadaptations are similar to synaptic changes associated with learning, including changes in dendritic morphology and ionotropic glutamate receptors (e.g., AMPA/NMDA), which result in long-term potentiation (LTP) and long-term depression (LTD) 11, 12 . These neuroadaptations result in pathological changes in brain morphology that seem to be salient enough to be observed macroscopically with MRI, as shown by neuroimaging studies in humans and animal models 13, 14 . Neuroimaging studies using magnetic resonance imaging (MRI) have specifically shown alterations in grey and white matter in SUDs 15, 16 . However, the involved regions vary widely and seem to depend on the type of substance, the consumption severity, the age of first use, the total time of usage, and other associated comorbidities. Morphometric studies investigating the MANUSCRIPT Pando-Naude, Victor Garza-Villarreal, Eduardo A. effects of SUDs using volumetric measures such as voxel-based morphometry (VBM), have reported both lower and higher volume in cortical and subcortical gray matter (GM) 17,18 and white matter (WM) 19, 20 . For example, alcohol use disorder (AUD) studies have shown lower GM volume of the amygdala, insula, cingulate gyrus, orbitofrontal gyrus and thalamus 15 , while tobacco use disorder (TUD) studies have shown lower GM volume in thalamus, cingulate gyrus, prefrontal cortex and cerebellum 21 . Cocaine use disorder (CUD) studies have shown lower GM volume in thalamus, insula, orbitofrontal cortex, anterior cingulate cortex, superior temporal cortex and cerebellum. 22 Conversely, other studies of these same substances have shown higher GM volume in putamen and other nuclei of the basal ganglia 23, 24 . Similarly, WM studies have shown different substances affecting different areas in distinct manners. For example, studies of AUD, TUD and CUD have shown lower volume of WM in the corticospinal tract, thalamic radiations and the corpus callosum 21, [25] [26] [27] . Overall, the structural pathology seems to be both convergent and divergent in terms of localization in between studies, suggesting a complex picture. Given these findings, it is unclear how SUDs affect brain morphology and how to differentiate between distinct changes caused by substance toxicity and substance dependency 28 . Potential reasons for the variability in findings may include: (1) study definitions (substance use disorder vs addiction vs dependency), (2) polysubstance use, (3) the substance user characteristics, such as age or time of substance use, and (4) methodological differences between morphometric studies (i.e. software used). Thus, a meta-analysis of brain imaging studies provides an opportunity to better understand the mechanisms by which SUDs affect brain morphology, of great interest for treatment follow-up as well as potential marker of therapy success. In this systematic review and meta-analysis of VBM studies, we aimed at finding the overall effect of SUDs in GM and WM volume, and to differentiate the possible mechanisms behind such effects by means of subgroup analyses of the type of substance, consumption severity, age and associated comorbidities. This systematic review and meta-analysis followed procedures from the Cochrane Handbook for Systematic Reviews 29 , and from the Center for Reviews and Dissemination (https://www.york.ac.uk/crd/). The review protocol was pre-registered in PROSPERO (CRD42017071222). This review was carried in accordance with the PRISMA 30 . We conducted a systematic literature search in PubMed, Scopus and PsycInfo, using both keywords and MeSH The meta-analytic results (ALE maps) were visualized using Mango (www.rii.uthscsa.edu/mango) on the MNI152 1mm standard brain, and resulting coordinates were cross-referenced to the Harvard-Oxford Cortical and Subcortical Atlas and the Juelich Histological Atlas via NeuroVault 37 and FSLeyes 38 , respectively. Finally, we performed the Fail-Safe N analysis (FSN) 39 as a measure of robustness against potential publication bias. It refers to the amount of contra-evidence that can be added to a meta-analysis before the results change, and can be obtained for each cluster that survives thresholding in an ALE meta-analysis. A higher FSN indicates more stable results and hence a higher robustness. A total of 797 records were identified through database searching, and after removing duplicates, 420 records were initially screened by title and abstract. A total of 140 articles were assessed for eligibility in the full-text screening stage. From these, 50 studies fulfilled criteria for eligibility and were included in both the qualitative and quantitative analyses (Supplementary Figure 1) . The characteristics of all studies included in the final meta-analysis are shown in Table 1 . Fifty studies met inclusion criteria and were included in the final quantitative meta-analysis, with a total of 538 foci and 88 experiments. The total number of participants was 4370, with 49.7% substance users (SU) and 50.3% heathy controls (HC). For the SU subsample, 59% in the addiction group (A), 8% on the long-term use group (LT), and 33% on the occasional use group (O). Alcohol was reported in 20% of studies, tobacco 22%, cocaine 12%, cannabis 12%, opioids 12%, stimulants 6%, ketamine 2%, and polysubstance use 14%. SUD was evaluated by a psychiatrist in 26% of studies, psychologist 8%, clinician 2%, while 64% failed to report the evaluator. The DSM-IV was used in 78% of studies, DSM-V 6%, while 16% failed to report the tool used to diagnose substance use disorder. All of the studies reported change in GM volume (100%), while 15 studies (30%) reported change in WM volume. Neuroimaging data was acquired in either 1.5 T (50%), or 3 T (50%) MRI scanners. Half of the studies were conducted in a Siemens MRI system, others were General Electric (26%), Phillips (22%), and MEDSPEC (2%). Most of the T1w-structural images were acquired using magnetization-prepared rapid acquisition with gradient echo sequence (MPRAGE), in 21 studies (42%), and 1mm 3 -voxel size in 27 studies (54%). VBM analyses were conducted in either SPM 40 (82%), FSL 38 (18%) or AFNI 41 (2%) (Supplementary Table 1 ). MRI quality of the included studies in the meta-analysis was assessed by a set of guidelines for the standardized reporting of MRI studies 32-34 (Supplementary Table 2 ). All studies reported the MRI design, software package and image acquisition, processing and analyses. Overall, good MRI practices were performed in the included studies. 3.3. Primary outcome. 8 MANUSCRIPT Pando-Naude, Victor Garza-Villarreal, Eduardo A. 8 The primary outcome was brain morphological differences measured by VBM between SU and HC, pooling all substances together, and defined as higher or lower volume. First, we included all substances and all reported coordinates and found two clusters in GM: left putamen and left thalamus; and one cluster in WM: right anterior thalamic radiation. Second, the comparison SU < HC (lower volume with use) resulted in 3 GM clusters: left thalamus, left insula and right anterior cingulate cortex; and one WM cluster: right anterior thalamic radiation. Finally, the comparison HC < SU (higher volume with use) resulted in one GM cluster: left putamen; and three WM clusters: right corticospinal tract, left superior longitudinal fasciculus and left optic radiation (Figure 1, Table 2 ). Pre-hoc subgroup analyses included (1) age of substance user: adolescents vs adults; (2) consumption severity: addiction vs long-term use vs occasional use; (3) type of substance: alcohol vs tobacco vs cannabis vs cocaine vs stimulants vs opioids vs ketamine, and papers that pooled together substances which we termed polysubstance; and (4) associated comorbidities: single vs multiple. Age and comorbidity subgroups resulted in insufficient experiments (foci) to conduct an ALE analysis (<15). However, we found significant ALE maps in the subgroups consumption severity and type of substance (Figure 2 ). The first subgroup meta-analysis reported ALE maps of substance users (SU) against healthy controls (HC), by type of consumption severity (addiction vs long-term use vs occasional use). We found significant ALE maps showing lower GM and WM volumes across all types of consumption. Additionally, higher GM volumes were also shown across all types of consumption, and higher WM only in long-term use (Figure 2, Supplementary Table 3 ). Figure 1 . Anatomic likelihood estimation meta-analytic results for studies comparing brain morphological changes between SU and HC, at cluster level inference p < 0.05 (FWE). The primary outcome included GM (top) and WM (bottom) volumetric alterations in SUDs. HC < SU = higher volume with use; SU < HC = lower volume with use. Significant ALE maps show lower volume in thalamus, insula and anterior cingulate cortex in GM, and thalamic radiations in WM; and higher volume in putamen GM, and corticospinal WM tract. Such results support the idea that the entire limbic loop of the basal ganglia shows neuroadaptations produced by SUD. Z, maximum Z-value. Pando-Naude, Victor Garza-Villarreal, Eduardo A. MANUSCRIPT Pando-Naude, Victor Garza-Villarreal, Eduardo A. Figure 2 . Subgroup anatomic likelihood estimation metaanalytic results for studies comparing brain morphological changes between SU and HC, at cluster level inference p < 0.05 (FWE). Subgroup analyses included consumption severity (top) and type of substance (bottom). HC < SU = higher volume with use; SU < HC = lower volume with use. Significant ALE maps showing lower GM and WM volumes across all types of consumption; higher GM volumes were also shown across all types of consumption; higher WM only in long-term use; lower GM volume in all substances, and higher GM volume only in tobacco, cannabis and polysubstance; lower WM volume in alcohol, tobacco and cocaine, and found no higher WM volume in any substance. Consumption: addiction (k=40) vs long-term use (k=4) vs occasional use (k=6). Substance: alcohol (k=10) vs tobacco (k=11) vs cannabis (k=6) vs cocaine (k=6) vs stimulants (k=3) vs opioids (k=6) vs ketamine(k=1), and papers that pooled together substances which we termed polysubstance (k=7). Z, maximum Z-value. Contrast analyses were performed for consumption severity (top) and type of substance (bottom) subgroups. Subgroups were tested for similarity (conjunction) and difference (subtraction) in a contrast analysis, to illustrate common and/or distinct areas between the elements of each subgroup analysis. ALE, anatomic likelihood estimation value; Z, maximum Z-value. We conducted contrast analyses between the ALE maps of each subgroup, to determine similarity (conjunction) and/or difference (subtraction) of affected brain regions between the types of consumption (Figure 3, Supplementary Table 4 ). By conducting a contrast analysis of the subgroup ALE maps, we specifically compared and contrasted brain regions across types of consumption severity. Addiction and long-term use were both associated with lower GM volume of the thalamus but differ in terms of lower GM of red nucleus, substantia nigra and putamen. These results support the idea that the thalamus is affected across all levels of SUD severity, and future research should focus on the correlation between SUD progression and the volume/form of the thalamus, as its morphology may predict severity of the disease, and/or monitor the efficacy of treatments and therapies. Addiction and occasional use both show higher volume of the globus pallidus, while differ in lower volume of fronto-temporal areas including the medial frontal gyrus, anterior cingulate cortex and superior temporal gyrus, supporting cortical alterations in occasional use. Finally, long-term use and occasional use share higher volume of somatomotor cortices, due to possible drug intoxication. In terms of WM, addiction and longterm use share lower volume of the anterior thalamic radiations and the corpus callosum, suggesting also a probable correlation between the progression of SUD and the severity in WM structural alteration. In the second subgroup meta-analysis of GM morphometry, we reported ALE maps of substance users (SU) against healthy controls (HC) by type of substance. Given that we only included one publication on ketamine, this substance was not included in the subgroup analysis. We found significant ALE maps showing lower GM volume in all substances, and higher GM volume only in tobacco, cannabis and polysubstance. Also, we found lower WM volume in alcohol, tobacco and cocaine, and found no higher WM volume in any substance (Figure 2 We conducted contrast analyses between the ALE maps of each subgroup, to determine similarity (conjunction) and/or difference (subtraction) of affected brain regions between the types of substance (Figure 3, Supplementary Table 6 ). By conducting a contrast analysis of the subgroup ALE maps, we wished to test specifically which brain areas are similar and different between the types of substances. Alcohol, overall, differed with most of the other substances including tobacco, cocaine, cannabis and opioids. Conversely, cannabis shared affected areas with tobacco, opioids, stimulants, and polysubstance. Consistent affected shared areas included thalamus, insula, inferior frontal gyrus and superior temporal gyrus in GM; and anterior thalamic radiation in WM. Although most addictive substances share a common neurobiological process in the reward circuitry, it is evident that neuroadaptations in SUD depend on the type of substance used. Results of this subgroup analysis by substance is valuable for future research into the best approach for therapeutics (pharmacological and behavioral), as treatment effects can be correlated with brain morphometry. In this systematic review and meta-analysis, we used coordinate-based anatomic likelihood estimation (ALE) to pool the effects of substance use disorders (SUDs) on brain regional volume. We found that the most converging regions with volume pathology in SUDs were putamen, thalamus, insula and anterior cingulate cortex in gray matter (GM), and the thalamic radiation, corticospinal tract and corpus callosum in white matter (WM). We found that consumption severity and type of substance subgroups resulted in significant ALE maps with both shared and distinctive regions involved, supporting converging and divergent effects depending on severity and type of substance use. Overall, the included publications succeeded in clearly stating their research question, population, inclusion and exclusion criteria, measurements and outcomes. We found that most of the publications failed to report the type of evaluator (e.g. psychiatrist), and some did not mention if the DSM or other tool was used to diagnose SUD. In terms of MRI characteristics and quality of the studies, we found that all included studies used state-of-the-art techniques and statistical tools, and therefore support the standardization of neuroimaging studies as a key element in future research and reproducibility efforts 32-34 . However, a larger effort is needed to provide diagnosis criteria, which would result in improved classifications for future reviews and meta-analyses. SUDs seems to disrupt the normal function of the limbic loop of the basal ganglia 3 . Repeated dopaminergic stimulation secondary to substance use, induces persistent neuroplastic adaptations in cortical and subcortical regions that seem to progress with the severity of the SUD 42 . Indeed, we found volumetric alterations in putamen, thalamus, insula and anterior cingulate cortex in GM, and internal capsule and thalamic radiations in WM, supporting the idea that the entire limbic loop of the basal ganglia shows neuroadaptations produced by SUDs. Higher volume of the putamen may be explained by the repeated glutamatergic spikes onto dopamine neurons (VTA/SNc) and into MSN in dorsal and ventral striatum, due to repeated MANUSCRIPT Pando-Naude, Victor Garza-Villarreal, Eduardo A. substance use, and supported by behavioral changes in reward responsivity and habituation that characterize SUDs. Noticeably, almost all regions of the neocortex project direct input to the striatum. Most of these projections come from association areas in frontal and parietal lobes, with contributions from temporal, insular, and cingulate cortices. These projections (corticostriatal pathway) travel via the internal capsule to reach the caudate and putamen 43 . We also found higher WM volume of the internal capsule in SUDs, suggesting neuroadaptive processes in this pathway as well. It has been suggested that SUDs or addiction are a disease of self-control 44 . Although the study of SUDs has been focused mainly on the role of dopamine and the reward system, new findings of clinical studies have revealed neuroplastic mechanisms in frontocortical regions that may underlie reward-seeking behavior 14 . In susceptible individuals, certain stimuli may activate strong urges that are not congruent with a given context. The lack of a proper inhibitory control may keep these urges in control up to a point, when stronger impulses and deficient inhibition result in impulsive or compulsive behavior 45 . Current models of SUDs suggest that impulsivity and compulsivity characterize the pathological behavior and help explain our structural results 3 . It has been proposed that the insula and the anterior cingulate cortex form the salience network (SN), that coordinates between the default mode network (DMN) and the central executive network (CEN) 46 . In our study we found lower volume of the insula, a region whose morphology has been associated with substance use compulsion and severity 47 . The insula plays a major role in interoception by integrating information from the internal physiological state, and projecting information to the ACC, ventral striatum and prefrontal cortex to initiate adaptive responses 48 . In SUDs, the insula's ability to switch between networks seems to be affected, as well as its functional connectivity with the ACC, amygdala and putamen 49-51 . Similarly, SUD neuroimaging studies have shown disrupted activity of the ACC 3 , involved in inhibitory control 52 , and altered connectivity with the insula 99 . The rostral part of the ACC is implicated in error-related responses, including affective processing, and the caudal part of the ACC is associated with detection of conflict to recruit cognitive control 53 . Thus, reduction in inputs from prefrontal and cingulate cortices into striatum may disrupt the control over action selection 54 . Finally, we found that SUDs were associated with lower thalamic GM/WM across several substances including alcohol, cocaine, nicotine, methamphetamine, opioids and cannabis 55,56 . Reduced structural and functional integrity of the thalamus and its connectivity appear to be associated with the severity of SUD 57 . Overall, there are brain regions consistently affected in all SUDs, with diverging MRI manifestations (higher vs lower volume) suggesting different underlying structural pathology between brain regions. We found that the effect of substance use in the brain seems to vary across the severity of consumption. Cortical structures seem affected in occasional use, while established addictive consumption (addiction) seems to also affect subcortical regions of the brain such as thalamus and basal ganglia. In addiction, such disrupted GM areas may presumably be co-affected with its respective WM thalamic radiation and corpus callosum connection, as seen in our results. We also found that occasional use affects WM tracts of the cingulum, connecting the limbic system with areas such as the cingulate gyrus, entorhinal cortex and temporal lobe. Neuroimaging studies have found that disruption of the posterior cingulum is associated to cognitive impairment 58 . The forceps minor connects the lateral and medial surfaces of the frontal lobes and crosses the midline via the genu of the corpus callosum 43 , and also showed structural alterations in occasional use. Along with the anterior thalamic radiation, the forceps minor connects ACC and striatum to the anterior frontal regions, modulating executive functions 59 . Various physiological mechanisms such as oxidative stress, mitochondrial dysfunction or neurotrophic factor dysfunction might account for the observed cortical GM volume reductions in occasional use 60 . However, repeated dopaminergic stimulation from substance abuse produce neuroadaptations (e.g., dendritic morphology and ionotropic glutamate receptors), that result in long-term potentiation (LTP) and long-term depression (LTD) 12 of the basal ganglia neurocircuitry 3 . These results suggest that cortical morphological pathology in SUDs appears before subcortical pathology or that subcortical pathology is only seen when addiction is established. This needs to be explored further with longitudinal studies. Reward processes are shared between substances, namely repeated stimulation into the VTA which releases dopamine into the ventral striatum 3 . However, the stimulation of the mesolimbic system depends on the different molecular targets for each kind of substance. For example, alcohol, unlike most other drugs, affects a wide range of targets and indirectly increases dopamine in the NAc 61 . Stimulants like amphetamine and cocaine block dopamine transporters, thus increasing dopamine in NAc 62 . Cannabis activates receptors that release neurotransmitters (GABA/Glutamate), modulating the activity of the mesolimbic system. Opioids, agonists of mu opioid receptors (MOR) in VTA, increase striatal dopamine release 63 . Nicotine and its interactions with nicotinic acetylcholine receptors, increases neuronal activity in VTA 64 . In our results, most of the substances show a convergent effect and region, namely lower volume of the thalamus. MANUSCRIPT Pando-Naude, Victor Garza-Villarreal, Eduardo A. Divergently, alcohol seems to affect frontal areas including superior and medial frontal gyrus, as well as ACC. Tobacco use shows a myriad of alterations including lower volume in insula and posterior areas of the DMN, such as PCC and precuneus. Cocaine users show lower volume of the claustrum, a structure that connects prefrontal areas with the thalamus, and has close proximity to the insula and putamen 65 . Cannabis use reduces the volume of temporal areas and thalamus, and increases the volume of putamen, while opioid use affects cortical fronto-temporal areas. Stimulant use mainly reduces GM volume of the frontal lobe. Polysubstance studies, as expected, show a wide variety of affected areas including lower volume of the anterior cingulate gyrus, thalamus, and superior temporal gyrus, and show higher volume of the subcallosal gyrus. In terms of WM, the affected convergent regions were the corticospinal tract, anterior thalamic radiation, the corpus callosum, and the cingulum. Overall, different substances show convergent and divergent morphological pathology, suggesting different physiopathology and possibly therapeutic approaches in SUDs that need to be considered. To conduct the anatomic likelihood estimation meta-analysis, we pooled peak coordinates derived from the included studies, rather the original raw structural MRI images. The accuracy of our findings relies on the result of a statistical estimation of coordinate-based anatomic foci (input), treated as spatial probability distributions centered at the given coordinates. The heterogeneity among the methods used in the included studies, such as preprocessing software, smoothing, statistical thresholds, characteristics of the participants, medication history and comorbidity, represent potential confounders. Meta-regression analysis is not compatible with GingerALE, which would have shown important insights when testing for heterogeneity (e.g. age of participants, age of first use, total years of SUD). As traditional meta-analyses, coordinate-based meta-analyses such as ALE can be subject to different forms of publication bias which may impact results and invalidate findings (e.g., the file drawer problem). We performed the Fail-Safe N analysis (FSN) 39 as a measure of robustness against potential publication bias. It is estimated for normal human brain mapping that a 95% confidence interval for the number of studies that report no local maxima varies from 5 to 30 per 100 published studies. Using the upper bound and the fact that our meta-analysis consists of 50 experiments, a possible estimate for the number of experiments that remain in the file drawer is 15. Therefore, the minimum FSN was defined as 15 (Supplementary Table 7 ). In our study, we tested 11 clusters resulting from our primary outcomes. We found that all clusters showed an FNR greater or equal than the minimum imposed of 15. FNR was >350 for clusters resulting from all GM foci analysis; and >300 for clusters resulting from all WM foci analysis. Thus, indicating a robust convergence of foci in these regions but also indicating that proportionally fewer studies are needed to obtain this effect. Two clusters from the comparison GM SU